Compare Nexgen Energy Ltd. Common Shares (NXE) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nexgen Energy Ltd. Common Shares vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Nexgen Energy Ltd. Common Shares trades at $8.8 (market cap $5.80B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 4.4× Nexgen Energy Ltd. Common Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Nexgen Energy Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nexgen Energy Ltd. Common Shares for 0 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| NXE | RPRX | |
|---|---|---|
Market Cap | $5.80B | $25.27B |
Volume | 6,795,738 | 3,671,183 |
Sector | Energy | Health |
52-Week High | $13.92 | $63.96 |
52-Week Low | $7.56 | $35.44 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.55B | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nexgen Energy Ltd. Common Shares
NexGen Energy develops uranium projects in Canada. Its main asset is the Rook I Project in Saskatchewan, which includes the Arrow uranium deposit.
Read more on NXE →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
